Ankur Sethi, MD
Cardiologist | Interventional Cardiology
901 W Main St Cn 5050, Ste 208 Freehold NJ, 07728About
Dr. Ankur Sethi is an interventional cardiologist practicing in Freehold, NJ. Dr. Sethi specializes in diagnosing, monitoring, and treating diseases or conditions of the heart and blood vessels and the cardiovascular system. These conditions include heart attacks, heart murmurs, leaky heart valve, valvular obstruction, other valvular heart disease, peripheral artery disease, coronary heart disease, and hypertension. He is an expert in endovascular or transcatheter treatment ( minimally invasive) for valvular heart disease, peripheral and coronary artery disease.
Education and Training
UCMS MBBS 2006
Board Certification
Cardiovascular Disease (Internal Medicine)
Interventional Cardiology (Internal Medicine)
Certification Board of Nuclear Cardiology
National Board of Echocardiography
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Areas of expertise and specialization
Faculty Titles & Positions
- Structural Heart disease committee member Society of Cardiovascular Angiography and Interventions 2023 - Present
- Professor Rutgers Robert Wood Johnson Medical School -
Fellowships
- Chicago Medical School cardiovascular disease
- Icahn School of Medicine at Mount Sinai Interventional Cardiology
Professional Society Memberships
- American College of CardiologySociety of Cardiovascular Angiography and Interventions
Articles and Publications
- Sandhaus M, Hiltner E, Takebe M, Sengupta P, Russo M, Sethi A. Acute Device-Related Thrombus Elimination During Transcatheter Edge-to-Edge Repair Via Vacuum Catheter Aspiration. JACC Case Rep. 2024 Jan 11;29(4):102162. doi: 10.1016/j.jaccas.2023.102162. PMID: 38379653; PMCID: PMC10874901.Hiltner E, Shukla A, Patel P, Russo M, Sethi A. Radiofrequency Ablation for Prevention of Outflow Tract Obstruction in Percutaneous Mitral Valve-in-Valve Replacement. JACC Case Rep. 2022 Oct 5;4(19):1247-1251Hiltner E, Erinne I, Singh A, Chen C, Kassotis J, Russo M, Sethi A. In-Hospital Outcomes of Surgical Aortic Valve Replacement at Transcatheter Valve Implantation Centers. Am J Cardiol. 2022 Sep 14:S0002-9149(22)00841-4. doi: 10.1016/j.amjcard.2022.08.003. Epub ahead of print. PMID: 36114022.Erinne I, Hiltner E, Bhasin V, Parikh N, Tangel R, Chen C, Russo MJ, Kassotis J, Sethi A. Sex Disparities in the Treatment of Aortic Stenosis and Related Outcomes: An Analysis of the National Inpatient Sample. Cardiology. 2022 Sep 14. doi: 10.1159/000526255. Epub ahead of print. PMID: 36103808.Bhasin V, Hiltner E, Singh A, Elsaid O, Awasthi A, Kassotis J, Sethi A. Disparities in Drug-Eluting Stent Utilization in Patients With Acute ST-Elevation Myocardial Infarction: An Analysis of the National Inpatient Sample. Angiology. 2022 Aug 17:33197221121027. doi: 10.1177/00033197221121027. Epub ahead of print. PMID: 35977920.Russo M, Chen C, Sethi A, Hakeem A. TAVR in an XXXL annulus (1057mm2 ) with type I bicuspid aortic valve. Catheter Cardiovasc Interv. 2022 Jul 6. doi: 10.1002/ccd.30325. Epub ahead of print. PMID: 35791643.Hiltner E, Erinne I, Singh A, Chen C, Kassotis J, Russo M, Sethi A. Contemporary trends and in-hospital outcomes of mechanical and bioprosthetic surgical aortic valve replacement in the United States. J Card Surg. 2022 Apr 13. doi: 10.1111/jocs.16499. Epub ahead of print. PMID: 35419890.Sethi A, Hiltner E, Wise J, Russo M. Percutaneous Mitral Valve-in-Valve Replacement Through Occluded Inferior Vena Cava. Struct Heart. 2022 Mar 29;6(2):100016. doi: 10.1016/j.shj.2022.100016. PMID: 37273742; PMCID: PMC10236862.Hakeem A, Tang D, Patel K, Sethi A, Awasthi A, Zakir R, Vagaonescu T. Safety and Efficacy of Single-Access Impella for High-Risk Percutaneous Intervention (SHiP). JACC Cardiovasc Interv. 2022 Feb 14;15(3):347-348. doi: 10.1016/j.jcin.2021.11.007. PMID: 35144797.Erinne I, Sethi A, Johannesen J, Kassotis J. Racial disparities in the treatment of aortic stenosis: Has transcatheter aortic valve replacement bridged the gap? Catheter Cardiovasc Interv. 2021 Feb 1. doi: 10.1002/ccd.29487Chen C, Okoh AK, Suhotliv A, Erinne I, Chaudhary A, Hakeem A, Sethi A, Salahuddin A, Lee LY, Russo MJ. Single Session Transesophageal Echocardiography and Transcatheter Mitral Valve Repair Using MitraClip in the COVID-19 Era. JACC Cardiovasc Interv. 2021 Jul 26;14(14):1618-1620. doi: 10.1016/j.jcin.2021.04.019. PMID: 34294403; PMCID: PMC8462016.Chen C, Okoh AK, Stump K, Smith M, Pannebianco C, Sethi A, Lee LY, Russo MJ. Expedited Mitra clip: Rapid evaluation, treatment, and discharge in the COVID-19 era. Cardiovasc Revasc Med. 2020 Nov 16:S1553-8389(20)30686-2.Sethi A, Kodumuri V, Prasad V, Kassotis J. Ultrathin biodegradable polymer sirolimus-eluting stent versus contemporary durable polymer everolimus-eluting stent for percutaneous coronary intervention: a meta-analysis of randomized trials [published online ahead of print, 2020 Sep 4]. Coron Artery Dis. 2020;10.1097Sethi A, Kodumuri V, Prasad V, Chaudhary A, Coromilas J, Kassotis J. Does the Presence of Significant Mitral Regurgitation prior to Transcatheter Aortic Valve Implantation for Aortic Stenosis Impact Mortality? - Meta-Analysis and Systematic Review. Cardiology. 2020;145(7):428-438. doi:10.1159/000506624Sethi A, Singbal Y, Prasad V. Is it time to abandon drug-eluting stents for saphenous venous graft percutaneous coronary intervention? EuroIntervention. 2019 Jun 20;15(2):209-210.Sethi A, Singbal Y, Kodumuri V, Prasad V. Inpatient mortality and its predictors after pericardiocentesis: An analysis from the Nationwide Inpatient Sample 2009-2013. J Interv Cardiol. 2018 Dec;31(6):815-825.Sethi A, Singbal Y, Rastogi U, Prasard V. Late incomplete stent apposition is associated with late/very late stent thrombosis A meta-analysis. Catheter Cardiovasc Interv. 2018 Feb 15;91(3):365-375.Kodumuri V, Balasubramanian S, Vij A, Siddamsetti S, Sethi A, Khalafallah R, Khosla S. A Meta-Analysis Comparing Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Disease. Am J Cardiol. 2018 Apr 15;121(8):924-933.Sethi A, Bajaj A, Khosla S, Arora R. Statin use mitigate the benefit of omega-3 fatty acids supplementation - A meta-regression of randomized trials. Am J Ther. 2016 May-Jun;23(3).Sethi A, Malhotra G, Singh S, Singh PP, Khosla S. Efficacy of Various Percutaneous Interventions for In-Stent Restenosis: Comprehensive Network Meta-Analysis of Randomized Controlled Trials. Circ Cardiovasc Interv. 2015 Nov;8(11).Sethi A, Arora R. Mortality risk with dual antiplatelet therapy? Lancet. 2015 Oct 17;386(10003):1534-5.Bajaj A, Sethi A, Rathor P, Suppogu N, Sethi A. Acute Complications of Myocardial Infarction in the Current Era: Diagnosis and Management. J Investig Med. 2015 Oct;63(7):844-55.Singh S, Sethi A, Singh M, Khosla K, Grewal N, Khosla S. Simultaneously measured inter-arm and inter-leg systolic blood pressure differences and cardiovascular risk stratification: a systemic review and meta-analysis. J Am Soc Hypertens. 2015 Aug;9(8):640-650.Bajaj A, Sethi A, Rathor P, Suppogu N, Sethi A. Acute Complications of Myocardial Infarction in the Current Era: Diagnosis and Management. J Investig Med. 2015 Oct;63(7):844-55.Sethi A, Arora RR, Khosla S. Antiplatelet and anticoagulant nonuse for acute myocardial infarction in the emergency department: An analysis from the National Hospital Ambulatory Medical Care Survey, 2002-2010. Curr Res Cardiol 2015, 2 (2): 77- 83.Malhotra G, Sethi A, Arora R. Hypertriglyceridemia and Cardiovascular Outcomes. Am J Ther. 2014 Nov 20.Sethi A, Bajaj A, Malhotra G, Arora R, Khosla S. Diagnostic Accuracy of Sensitive or High sensitive Troponin on Presentation for Myocardial Infarction A Meta-analysis and systematic review. Vasc Health Risk Manag. 2014; 10:435-50.Sethi A, Bajaj A, Bahekar A, Bhuriya R, Singh M, Ahmed A, Khosla S. Glycoprotein IIb/IIIa inhibitors with or without thienopyridine pretreatment improve outcomes after primary percutaneous coronary intervention in high risk patients with ST elevation myocardial infarction- a meta-regression of randomized controlled trials. Catheter Cardiovasc Interv. Catheter Cardiovasc Interv. 2013 Aug 1;82(2):171-81Sethi A, Singh M, Arora R. Omega-3 fatty acid supplementation and cardiovascular disease events. JAMA. 2013; 2;309:27-8.Sethi A, Bahekar A, Bhuriya R, Bajaj A, Singh PP, Arora R, Khosla S. Zotarolimus-eluting stent versus sirolimus-eluting and paclitaxel-eluting stents for percutaneous coronary intervention: A meta-analysis of randomized trials. Arch Cardiovasc Dis. 2012 ;105:544-56. Sethi A, Bahekar A, Bhuriya R, Bajaj A, Kovacs D,Ahmed A, Khosla S .Drug-eluting stent versus bare metal stent in ST elevation myocardial infarction at follow-up of three years or longer: A meta-analysis of randomized trials. Exp Clin Cardiol. 2012, Volume 17 Issue 4: 169-174.Sethi A, Bahekar A, Doshi H, Bhuriya R, Bedi U, Singh S, Khosla S. Tirofiban Use With Clopidogrel and Aspirin Decreases Adverse Cardiovascular Events After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: A Meta-analysis of Randomized Trials. Can J Cardiol. 2011;27: 548-54.Sethi A, Bahekar A, Bhuriya R, Singh S, Ahmed A, Khosla S. Complete versus culprit only revascularization in acute ST elevation myocardial infarction: a meta-analysis. Catheter Cardiovasc Interv. 2011 Feb; 77(2): 163-70.Bhuriya R, Singh M, Sethi A, Molnar J, Bahekar A, Singh PP, Khosla S, Arora R. Prevention of Recurrent Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers: A Systematic Review and Meta-Analysis of Randomized Trials. J Cardiovasc Pharmacol Ther. 2011 FebSethi A, Bahekar A, Bhuriya R. Is appropriate use criteria for cardiac radionuclide imaging in asymptomatic diabetic patients evidence based? J Am Coll Cardiol. 2010 Jan; 55(3): 260.Sethi A. Management of hyperlipidemia in patients with abdominal aortic aneurysm.. Ann Intern Med. 2009 Nov; 151(9): 670.Sethi A, Arora R. Ambulatory blood pressure as a predictor of cardiovascular risk. Arch Med Sci. 2009 Jan; 5(1): 3-9.Sethi A, Arora RR.. Medical management and cardiovascular risk reduction in peripheral arterial disease. Exp Clin Cardiol. 2008 Sep; 13(3): 113-9.
Areas of research
Valvular heart disease
Coronary artery disease
Transcatheter therapies
Ankur Sethi, MD's Practice location
Ankur Sethi, MD's reviews
Write ReviewMedia Releases
Renowned Cardiologist Brings Advanced Expertise to Robert Wood Johnson University Hospital Somerset and New Brunswick
Dr. Sethi, a distinguished interventional cardiologist affiliated with Heart Specialists of Central Jersey, is making waves in the medical community with his exceptional skills and expertise. Board-certified in interventional cardiology, cardiovascular disease, adult echocardiography, and nuclear cardiology, has been instrumental in performing groundbreaking procedures at Robert Wood Johnson University Hospital Somerset and New Brunswick.
A graduate of the University College of Medical Sciences in Delhi, India, he has amassed a wealth of experience in the field of cardiology. Following his medical degree, he completed an internal medicine residency at Chicago Medical School, and went on to pursue further specialization in cardiovascular disease at the same institution. He then honed his skills in interventional cardiology through a fellowship at the prestigious Icahn School of Medicine at Mount Sinai in New York.
Known for his expertise in complex coronary and peripheral vascular interventions, all achieved without the need for open surgery, Dr. Sethi has received additional training in cutting-edge percutaneous cardiac interventions, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral valve repair/replacement (MitraClip), and various other advanced procedures.
In addition to his clinical practice, he is also actively engaged in clinical research, with several publications in renowned journals such as the Journal of American College of Cardiology, Circulation Cardiovascular Interventions, Catheterization and Cardiovascular Interventions, and Canadian Journal of Cardiology. He also plays a vital role in educating the next generation of cardiologists and interventional fellows at Rutgers Robert Wood Johnson Medical School in New Brunswick.
Dr. Sethi's commitment to excellence, coupled with his passion for advancing the field of cardiology, has solidified his reputation as a leading interventional cardiologist. Patients and colleagues alike commend him for his compassionate care and unwavering dedication to improving cardiovascular health.
Recommended Articles
- Is Testicular Cancer Curable?
The testes are a pair of male sex glands located just beneath the penis and is encased in a loose fold of skin - the scrotum, and are responsible for producing testosterone - the male sex hormone, and for manufacturing sperms which are mobile male sex cells. Testicular cancer occurs when some of...
- Everest to End Duchenne: A Journey Against Duchenne Muscular Dystrophy
Latest research on Duchenne Muscular Dystrophy (usually abbreviated as DMD) have been actively pursuing different, exciting strategies and methods. Some of the most renowned ones that have been tested on humans in clinical trials recently are: gene repair, gene therapy and exon skipping. This...
- Parkinson's: Tips From a Professional Occupational Therapist
Once the diagnosis of Parkinson's has been dropped on a person, it is natural to feel devastated. Modern medicine can help a lot but still, it cannot stop the progression of the disease. However, with lifestyle changes a person can delay the progression of symptoms, and continue to live...
- Genetic Advancements in Lymphoma Treatment
Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...
- Alternative Treatments for Obesity
Obesity refers to the accumulation of extra body fat than the normal body requirement. If your body mass index (BMI) is above 30, then you are considered as obese. The factors that influence obesity include age, body build, sex, and height.Obesity can be treated without involving medication or...
- Beetroots Can Be Beneficial to Runners
A new study shows that runners may benefit from eating beetroot. Eating beetroot before a workout helped runners to improve their performance during a 5K run. “Baked beetroot food was compared to cranberry relish in its effect on runners in the study," says Margaret Murphy, RD, a Chicago dietitian...
Nearby Providers
- Vivian Akrive Kominos M.D.901 W Main St Freehold NJ 07728
- Lou-anne Beauregard M.D.901 W Main St Freehold NJ 07728
- Ashish Awasthi M.D.901 W Main St Freehold NJ 07728
- Arthur Okere M.D.555 Iron Bridge Road Freehold NJ 07728
- Sangeeta Garg Other555 IRON BRIDGE RD FREEHOLD NJ 07728
- Divya Menon M.D.901 W Main St Freehold NJ 07728